Gender differences in a clinical trial for prescription opioid dependence.
Level 3 - non-randomized controlled study
Secondary observational analysis of gender subgroups within a randomized controlled trial
PubMed 23313145 · doi:10.1016/j.jsat.2012.12.007
What was done
The authors conducted a secondary analysis of a large multicenter clinical trial to evaluate gender differences in baseline clinical characteristics, medication dose, treatment retention, and opioid use outcomes among individuals treated for prescription opioid dependence.
What was found
The abstract reports directional findings without specific numerical values or effect sizes. At baseline, there were no significant gender differences in opioid dependence severity. However, women reported significantly greater functional impairment, higher psychiatric severity, and a greater likelihood of using opioids to cope with pain and negative affect compared to men. Women were also significantly more likely to have initially received opioids via a legitimate prescription and to consume them via the intended route of administration. Men reported significantly more alcohol problems. Following treatment initiation, there were no significant differences between men and women in medication dose, retention in treatment, or opioid use outcomes.
Why it matters
These findings indicate that although women presenting for prescription opioid treatment carry a distinct psychiatric and functional burden relative to men, standard medication-based treatment yields comparable retention and opioid abstinence outcomes across genders.
Limits
The abstract provides no exact sample size, numerical data, confidence intervals, or p-values. Because gender is an observational subgroup variable rather than a randomized exposure, unmeasured confounding may influence baseline and outcome comparisons. Specific treatment modalities, medication types, and long-term post-trial outcomes are not detailed in the abstract.
Cited by
- supports Prescription medication addiction has a roughly equal gender ratio of 50/50 between men and women in clinical settings.